Delivery Order SPE2DB20D2014-SPE2DB24FC46U

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,240.66 firm-fixed-price delivery order is for the supply of 4,566,989,388 units of 20 mg Simvastatin tablets, a cardiovascular medication. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.04 firm fixed-price contract is for the delivery of 4,566,754,908 units of 20mg Simvastatin tablets, a cardiovascular medication, with a completion date of December 19, 2024. This award is part of an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
The U.S. Defense Logistics Agency (DLA) awarded a $2,729.60 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,560,784,924 units of Simvastatin 20 mg tablets. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,557,972,614 units of Simvastatin 20 mg tablets. The $22,517.07 fixed-price delivery order has an ultimate completion date of August 3, 2022 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of 4,562,331,338 units of SIMVASTATIN 20 MG TABLET 1000S, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The fixed-price delivery order, valued at $2,140.68, has an ultimate completion date of September 28, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award, which is a part of the...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Simvastatin 20 mg tablets. The contract, valued at $14,131.81, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of September 5, 2023 and is a firm fixed-price contract type. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award, valued at $2,224.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,565,239,896 units of Simvastatin 20 mg tablets and has a firm fixed-price pricing type. The award was not associated with any set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,390.16 firm fixed-price delivery order contract is for the supply of 4,566,948,919 units of Simvastatin 20 mg tablets. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award for $1,079.94 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, is for the supply of 1,000 units of 20 mg Simvastatin tablets. The contract has an ultimate completion date of February 2, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 4,564,659,961 tablets of Simvastatin 20 mg to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, and has a ceiling value of $2,565.06. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC46U
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, the corporate office division of AmerisourceBergen Corporation. The $1,267.22 firm fixed-price delivery order is for the supply of 4,565,133,851 Simvastatin 20mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment programs and facilities globally. The contract does not have a set-aside designation.

Generated 10/11/24, 9:24 AM